Genetic Creutzfeldt-Jakob disease in Sardinia: a case series linked to the PRNP R208H mutation due to a single founder effect.


Journal

Neurogenetics
ISSN: 1364-6753
Titre abrégé: Neurogenetics
Pays: United States
ID NLM: 9709714

Informations de publication

Date de publication:
10 2020
Historique:
received: 16 03 2020
accepted: 19 05 2020
pubmed: 28 5 2020
medline: 16 6 2021
entrez: 28 5 2020
Statut: ppublish

Résumé

In genetic prion diseases (gPrD), five genetic variants (E200K, V210I, V180I, P102L, and D178N) are responsible for about 85% of cases. The R208H is one of the several additional rare mutations and to date, only 16 cases carrying this mutation have been reported worldwide. To describe the phenotypic features of 5 affected patients belonging to apparently unrelated Sardinian (Italian) families with R208H gPrD, and provide evidence for a possible founder effect are the aims of this study. The R208H PRNP mutation has a much higher relative frequency in Sardinia than elsewhere in Italy (72% vs. 4.4% of gCJD cases). Our cohort shared similar phenotypic features to the previously described patients with R208H-129M haplotype with most patients showing the classical Creutzfeldt-Jakob disease (CJD) phenotype. The analysis of 10 controls and 5 patients by NGS sequencing identified 4 haplotypes, 3 associated with the wild type variant, and one (H1) shared by all patients carrying the 208His variant. This is the first report of a regional cluster for R208H mutation in gPrD and the first report of the presence of a common ancestor for this Sardinian R208H cluster, confirming the probable consequences of genetic isolation process even for rare diseases.

Identifiants

pubmed: 32458274
doi: 10.1007/s10048-020-00618-1
pii: 10.1007/s10048-020-00618-1
doi:

Substances chimiques

PRNP protein, human 0
Prion Proteins 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

251-257

Auteurs

Marta Melis (M)

SC Neurologia AOU Policlinico di Monserrato, Cagliari, Sardinia, Italy. mrtmelis@gmail.com.

Andrea Molari (A)

SC Neurologia e Stroke Unit AOB, Cagliari, Italy.

Gianluca Floris (G)

SC Neurologia AOU Policlinico di Monserrato, Cagliari, Sardinia, Italy.

Sarah Vascellari (S)

Dipartimento di Scienze Biomediche, Sezione di Microbiologia e Virologia, Università degli Studi di Cagliari, Cagliari, Italy.

Luisa Balestrino (L)

Genetica Medica, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Caligria, Italy.

Anna Ladogana (A)

Department of Neuroscience, Istituto Superiore di Sanità, 00161, Rome, Italy.

Anna Poleggi (A)

Department of Neuroscience, Istituto Superiore di Sanità, 00161, Rome, Italy.

Piero Parchi (P)

IRCCS Istituto delle Scienze Neurologiche di Bologna, 40139, Bologna, Italy.
Department of Experimental Diagnostic and Specialty Medicine (DIMES), Università di Bologna, 40138, Bologna, Italy.

Giovanni Cossu (G)

SC Neurologia e Stroke Unit AOB, Cagliari, Italy.

Maurizio Melis (M)

SC Neurologia e Stroke Unit AOB, Cagliari, Italy.

Sandro Orrù (S)

Genetica Medica, Dipartimento di Scienze Mediche e Sanità Pubblica, Università di Cagliari, Caligria, Italy.

Giovanni Defazio (G)

SC Neurologia AOU Policlinico di Monserrato, Cagliari, Sardinia, Italy.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH